NCT02341482 A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02332798 Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia Status COMPLETED Phase PHASE1
NCT02323269 Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve) Status TERMINATED Phase N/A
NCT02322021 Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT02294851 A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Intravenously Administered BMS-986168 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02292537 A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA) Status COMPLETED Phase PHASE3
NCT02283918 Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment Battery Status COMPLETED Phase N/A
NCT02283853 Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase PHASE3
NCT02269930 Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02255435 A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia Status COMPLETED Phase PHASE2
NCT02255422 RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR Status COMPLETED Phase PHASE2
NCT02241785 Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies Status TERMINATED Phase PHASE4
NCT02236624 Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis? Status COMPLETED Phase NA
NCT02234869 Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy Status WITHDRAWN Phase PHASE4
NCT02228707 Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02228395 Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02219932 Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis Status COMPLETED Phase PHASE3